Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05892770 · ClinicalTrials.gov registry record · Phase 1

Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia

A Phase 1 study of Spasmodic Dysphonia, sponsored by University of Florida.

Active
Registry status
Phase 1
Development phase
36
Enrollment target
1
Study location

NCT05892770 is a Phase 1 study of Spasmodic Dysphonia that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 36 participants, below the 109-participant average among 7 other Spasmodic Dysphonia trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05892770, a Phase 1 study of Spasmodic Dysphonia, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

One initial study has shown that Botulinum Toxin (BT) in combination with zinc supplementation may increase the duration of effects BT treatment. This initial study was in the context of facial aesthetics. The purpose of the present study is to determine the effect, if any, of oral zinc supplementation prior to BT in the treatment of spasmodic dysphonia. If positive effects will be observed, this would help reduce the burden of disease for these patients.

Conditions Studied

Spasmodic Dysphonia

Interventions

  • DRUG Botulinum toxin type A
  • DRUG Zinc gluconate supplement

Study Locations (1)

Florida

  • University of Florida- Shands Hospital - Gainesville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-08-01
Est. Completion 2025-12
Phase Phase 1

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05892770

The ClinicalTrials.gov registry entry for NCT05892770 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 7 other Spasmodic Dysphonia trials with a reported enrollment target (67% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spasmodic Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which Botulinum toxin type A is the first listed.

NCT05892770 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05892770 about?

NCT05892770 is a clinical study titled "Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia". One initial study has shown that Botulinum Toxin (BT) in combination with zinc supplementation may increase the duration of effects BT treatment. This initial study was in the context of facial aesthetics. The purpose of the present study is to determine the effect, if any, of oral zinc supplementat...

What is the current status of trial NCT05892770?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2023-08-01. Estimated completion is 2025-12.

What conditions does trial NCT05892770 study?

This clinical trial studies the following conditions: Spasmodic Dysphonia.

What interventions are being tested in trial NCT05892770?

The interventions under investigation include: Botulinum toxin type A (DRUG), Zinc gluconate supplement (DRUG).

Who is sponsoring clinical trial NCT05892770?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05892770 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spasmodic Dysphonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Spasmodic Dysphonia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.